Tissue-Based Testing
News on immunohistochemistry and other tissue-based testing methods.
Foundation Medicine Nabs Five-Year VA Contract for Tumor Molecular Profiling of Cancer Patients
The national contract covers FoundationOne CDx, FoundationOne Liquid CDx, FoundationOne RNA, and FoundationOne Heme.
Agendia Gets CE-IVDR Certification for MammaPrint, BluePrint FFPE Breast Cancer Tests
The assays are versions of Agendia’s MammaPrint and BluePrint tests that use formalin-fixed paraffin-embedded tissue samples instead of fresh tissue.
The team's modification of HotSHOT extraction methods is meant to deliver simple, inexpensive testing to resource-limited areas of sub-Saharan Africa.
Nucleai to Integrate Predictive Biomarker Tech Into Proscia Digital Pathology Platform
The companies will integrate Nucleai's technologies into Proscia's cloud-based Concentriq digital pathology platform.
Foundation Medicine, PMV Pharma Ink Deal to Develop CDx for Investigational Solid Tumor Therapy
The tissue-based FoundationOne CDx test will be developed as a companion diagnostic for rezatapopt, PMV Pharma's investigational, selective p53 reactivator.